The prevalence and risk factors of orthostatic hypotension with cardiovascular diseases: An observational study

Author:

Yang Zhongxue1,Liu Jie1,Meng Fan1,Zhang Luqi1,Zhen Yanjie1,Wang Kai1,Chen Ni1,Zhao Bin1

Affiliation:

1. Second Hospital of Hebei Medical University

Abstract

Abstract Background: Cardiovascular disease can aggravate the degree of blood pressure drop in patients after standing, causing orthostatic hypotension, thus leading to the occurrence of adverse events such as syncope and fall. The focus of this study was to describe the prevalence and explore risk factors of orthostatic hypotension in patients with cardiovascular disease. Methods: An observational study was conducted on patients who had cardiovascular disease from October 2021 to October 2022 in a hospital in Hebei Province, China. Blood pressure was measured in the supine position and within 3min after standing. Data on demographic data, combined disease, taking anti-hypertensive drugs and examination indicators were collected by using a physician-administered questionnaire and clinical records. A logistic regression was used for the risk factors of orthostatic hypotension in hospitalized patients with cardiovascular disease. Results: The study included 759 patients with a mean age of 62.0 (55.0–68.0) years, male predominance (68.0%, n = 516), and orthostatic hypotension (23.8%, n = 181). The results of multivariate Logistic regression analysis showed that age [compared to the age group of [18,41), the OR (95%CI) for the age group of [61,71) was 6.182 (1.390 ~ 27.497), the OR (95%CI) for the age group of ≥ 71 years was 5.007 (1.059 ~ 23.676)], combined arrhythmia[compared with no combined arrhythmia, the combined arrhythmia OR (95%CI) was 3.552 (2.223 ~ 5.674)], higher mean systolic BP in the supine position[the OR (95%CI) was 1.029 (1.014 ~ 1.043)], higher total cholesterol [the OR (95%CI) was 1.252(1.013 ~ 1.546)], take calcium channel blockers anti-hypertensive drugs[compared with not taking calcium channel blockers anti-hypertensive drugs, the OR (95%CI) for taking calcium channel blockers anti-hypertension drugs was 1.661(1.062 ~ 2.597)], take β-blocker anti-hypertensive drugs [compared with not taking β-blockers anti-hypertensive drugs, the OR (95%CI) for taking β-blockers anti-hypertensive drugs was 1.985(1.262 ~ 3.125)] were risk factors for orthostatic hypotension in hospitalized patients with cardiovascular disease. Conclusion: The prevalence of orthostatic hypotension in cardiovascular disease inpatients are high. Health care providers should pay more attention to orthostatic hypotension, carry out targeted prevention and management measures for key groups with risk factors, reduce the incidence of adverse events, improve the quality of nursing, and promote the health recovery of patients.

Publisher

Research Square Platform LLC

Reference47 articles.

1. Liming Y, Ying W, Guozhen S, Junqiao W, Li Y, Rong H et al. Internal medicine nursing (6th Edition).In:Liming Y, Ying W editors. Beijing:People's Medical Publishing House, 2017.(in China).

2. hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.Neurology.1996;Consensus statement on the definition of orthostatic

3. Hypotension: JACC State-of-the-Art Review;Freeman R;J Am Coll Cardiol

4. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome;Freeman R;Clin Auton Res,2011

5. Low-Level Vagus Nerve Stimulation Attenuates Myocardial Ischemic Reperfusion Injury by Antioxidative Stress and Antiapoptosis Reactions in Canines;Chen M;J Cardiovasc Electrophysiol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3